Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Recurrence 1Lung Neoplasms 1Head and Neck Carcinoma 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Monitoring, Physiologic × 1 year × Clear all
NCT02649569 2026-04-13

Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer

Montefiore Medical Center

Completed
41 enrolled
Thoracic

Lung Neoplasms

NCT05080998 2025-11-10

LOBSTER

Pacific Edge Limited

Recruiting
450 enrolled

Recurrence

NCT03489252 2025-08-22

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Thomas Jefferson University

Phase NA Completed
41 enrolled
Head & Neck

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡